Roche Hopes To Gain Broad Market For Tecentriq In Adjuvant NSCLC

Interim ASCO Data Show Improvement in PD-L1 Expressors, All-Comers

 
• By Alaric DeArment
  
Doctor examining at lungs radiograph x-ray film of patient in operation room. medical concept.
Roche unveiled data from its Phase III study of Tecentriq in adjuvant NSCLC at ASCO • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences